secwatch.observer — SEC 8-K summary
======================================

Issuer:     LIPELLA PHARMACEUTICALS INC. (LIPO)
CIK:        0001347242
Form:       8-K
Filed at:   2023-11-22T23:59:59+00:00
Accession:  0001753926-23-001529
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Lipella shareholders elect all 7 directors, approve share plan increase, ratify auditor
--------------------------------------------------------------------------------

- Seven director nominees elected with ~2.22M to ~2.24M votes for each; 184,927 broker non-votes.
- Amendment to 2020 Stock Incentive Plan approved (1.57M for, 670k against); authorized shares increased by 1M to 2.4M.
- Ratification of Urish Popeck & Co. as independent auditor approved (2.42M for, 175 against).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1347242/000175392623001529/0001753926-23-001529-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1347242/000175392623001529/g083865_8k.htm
  HTML page:      https://secwatch.observer/filing/0001753926-23-001529

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer